Expert Review of Respiratory Medicine

Expert Review of Respiratory Medicine is a MEDLINE-indexed journal of expert review and original papers on obstructive, restrictive, vascular and infectious respiratory disease, published by Taylor & Francis.《呼吸医学专家评论》是一份被 MEDLINE 收录的期刊，刊载阻塞性、限制性、血管性与感染性呼吸系统疾病的专家综述与原创论文，由 Taylor & Francis 出版。

The title is built around review articles, and each review is meant to place a recent body of work into a clinical setting.该刊以综述文章为主干，每篇综述意在把近期的一批工作放到临床情境之中。

In the 2025 edition of the journal citation report it holds an impact factor of 3.3 and stands in the second quartile of the respiratory system.在 2025 年版期刊引证报告中，该刊的影响因子为 3.3，在呼吸系统类目中列第二区。

Scope

• Review articles stand at the centre of the journal, and each of them is expected to weigh a field rather than to list what has been published.综述文章居于该刊的中心，每篇综述都要求权衡某一领域，而非罗列已发表的内容。

• Original papers are admitted beside the reviews, so that a new clinical result may also find a place in the journal.原创论文与综述并列收载，使新的临床结果也能在该刊找到位置。

• Obstructive respiratory disease is named as a subject, and the journal follows the conditions in which the airway is narrowed.阻塞性呼吸系统疾病被点名为选题，该刊追踪气道变窄的那一类病症。

• Restrictive disease is covered as well, and work on the conditions that limit the expansion of the lung is taken.限制性疾病同样得到覆盖，关于限制肺扩张的那类病症的工作受到收载。

• Vascular disease of the lung belongs to the scope, and the journal carries work on the pulmonary circulation and on its disorders.肺血管疾病属于收稿范围，该刊刊载肺循环及其相关疾病方面的研究。

• Infectious respiratory disease is admitted, and the journal takes papers on the pathogens that attack the airway and on their treatment.感染性呼吸系统疾病亦在接纳之列，该刊收载关于侵袭气道的病原体及其治疗的论文。

• The prospects for new and emerging therapeutics are named among the key areas, and the journal looks at what is coming rather than only at what is established.新出现疗法的前景被点名为关键领域之一，该刊关注将要到来的东西，而非只关注已经确立的东西。

• The epidemiology of respiratory disease is treated, and the journal carries work on how often a condition occurs and among whom.呼吸系统疾病的流行病学得到处理，该刊刊载某一病症发生频率及其人群分布方面的研究。

• Preventive strategies are covered, and the journal takes work on vaccination, on smoking and on other ways of lowering the burden.预防策略得到覆盖，该刊收载疫苗接种、吸烟以及其他减轻疾病负担途径方面的工作。

• Chronic obstructive pulmonary disease is examined in all its aspects, from the way a patient manages the illness at home to the systemic effects of the disease.慢性阻塞性肺疾病在其各方面得到考察，从患者在家的疾病管理，到该病的全身性影响。

• Comorbidities are part of the account, and the journal follows the other conditions that travel with a respiratory illness.合并症是这一叙述的一部分，该刊追踪与呼吸系统疾病相伴出现的其他病症。

• Improved diagnostic methods are a named area, and imaging techniques, biomarkers and physiological tests are all written into the statement.改进的诊断方法是点名领域，影像技术、生物标志物与生理学检验都写进了宗旨说明。

• The global burden of respiratory disease supplies the reason for the journal, since hundreds of millions of people live with a chronic respiratory condition.呼吸系统疾病的全球负担为该刊提供了存在的理由，数以亿计的人带着慢性呼吸系统疾病生活。

• Mortality from the common respiratory illnesses is set out as part of the case for the subject, and the editors keep that weight in view when they commission.常见呼吸系统疾病造成的死亡被列为选题理由的一部分，编辑方在约稿时始终记着这一分量。

History

• The journal dates from 2007, when the first volume was issued by Future Drugs in London.该刊可上溯到 2007 年，第 1 卷由 Future Drugs 在伦敦发行。

• At its launch the title was introduced by Peter Barnes of Imperial College London, who set out what the new journal meant to cover.在创刊之际，该刊由伦敦帝国理工学院的（Peter Barnes）引介，他说明了这份新刊打算覆盖什么。

• From 2015 the journal has been published from Abingdon in Oxfordshire by Taylor and Francis.自 2015 年起，该刊由 Taylor and Francis 在牛津郡的阿宾登出版。

• The journal has grown from a bimonthly into a monthly, and twelve issues are now gathered into a year.该刊由双月刊成长为月刊，如今每年汇集十二期。

• The print number is 1747-6348 and the electronic number is 1747-6356.印刷版编号为 1747-6348，电子版编号为 1747-6356。

• MEDLINE and PubMed have carried the title from its fourth volume in 2010.MEDLINE 与 PubMed 自 2010 年的第 4 卷起收录该刊。

• The impact indicator has moved from 3.772 and 4.3 to 2.9 and 2.7, and it stood at 3.3 in the 2025 edition.影响因子从 3.772 与 4.3 变为 2.9 与 2.7，在 2025 年版为 3.3。

• Around one paper in twenty is free to read on publication, and the journal follows the published open access arrangement of its house.约每二十篇论文中有一篇在出版时即可免费阅读，该刊遵循其出版方公布的开放获取安排。

• The publisher assembled a collection to mark twenty years of the journal, and the editors used it to look back over the changes the field has seen.出版方组织了一个专题集以纪念该刊二十年，编辑方借它回顾了这一领域经历的变化。

• The title belongs to a family of review journals issued under the same imprint, and it shares their editorial conventions.该刊属于同一出版品牌下的一族综述期刊，与它们共享编辑惯例。

• Besides MEDLINE the journal is indexed in several other abstracting services, and the list is published on its own pages.除 MEDLINE 之外，该刊还被若干其他文摘服务收录，名录公布在其自身页面上。

• The journal is treated as a review title in the citation reports, and its content is weighted towards synthesis rather than towards primary reporting.在引证报告中该刊被当作综述类刊物，其内容偏向综合而非首创性报告。

• The journal is read by pulmonologists and by internists, and the editors look for reviews that a busy clinician can use at the bedside.该刊的读者既有呼吸科医生也有内科医生，编辑方寻找忙碌的临床医生能在床旁用上的综述。

• Asthma and its management are covered alongside chronic obstructive pulmonary disease, and the journal follows the drugs used for both.哮喘及其管理与慢性阻塞性肺疾病并列得到覆盖，该刊追踪两者所用的药物。

• Sleep disordered breathing and the disorders that arise during sleep are admitted as part of the respiratory subject.睡眠呼吸障碍以及在睡眠中出现的疾患，作为呼吸系统选题的一部分受到收载。

• Interstitial lung disease is treated, and the journal carries work on the fibrotic conditions that stiffen the lung.间质性肺病得到处理，该刊刊载使肺变硬的纤维化病症方面的研究。

• Pulmonary rehabilitation is admitted, and the journal follows the programmes that help a patient cope with a long term condition.肺康复也在接纳之列，该刊追踪帮助患者应对长期病症的各种方案。

Editors

• The editor-in-chief is Joseph Blondeau of the University of Saskatchewan in Canada.主编是加拿大萨斯喀彻温大学的（Joseph Blondeau）。

• An editorial advisory panel backs the editor, and its members are drawn from respiratory medicine in Europe, North America and Australia.一支编辑顾问小组为总编提供支持，成员来自欧洲、北美与澳大利亚的呼吸医学界。

• Among them are Edward Abraham of the University of Alabama at Birmingham, Peter Barnes of Imperial College London, Kenneth Adler of North Carolina State University and Nico Ambrosino of Pisa.其中包括阿拉巴马大学伯明翰分校的（Edward Abraham）、伦敦帝国理工学院的（Peter Barnes）、北卡罗来纳州立大学的（Kenneth Adler）与比萨的（Nico Ambrosino）。

• Demosthenes Bouros of the Democritus University of Thrace and Gary Anderson of the University of Melbourne are also on the panel.色雷斯德谟克利特大学的（Demosthenes Bouros）与墨尔本大学的（Gary Anderson）也在该小组之列。

• Manuscripts are submitted through an online system and are sent to independent referees for peer review.稿件通过在线系统投递，并送交独立审稿人进行同行评审。

• The journal states that all of its material is rigorously peer reviewed, and it asks authors to follow the conventions of its house.该刊声明其全部内容都经过严格的同行评审，并要求作者遵循其出版方的惯例。

• Since the journal is built on reviews, editors commission much of what it prints, and proposed topics are welcome from the field.由于该刊以综述为主干，所载内容多由编辑约稿，学界提出的题目同样受到欢迎。

• Authors must declare any competing interests, and the journal follows the published ethics and disclosure policy of its publisher.作者须声明任何利益冲突，该刊遵循其出版方公布的伦理与披露政策。

• Open access is offered as an option beside the subscription route, and a paper may be made free on payment of a charge.该刊在订阅路径之外提供开放获取选项，付费后可使论文免费阅读。

• The editorial office answers queries by email and guides authors through submission and revision.编辑部以电子邮件答复查询，并引导作者完成投稿与修回。